HealthStream, Inc. (HSTM)
NASDAQ: HSTM · IEX Real-Time Price · USD
-0.10 (-0.36%)
At close: Jun 18, 2024, 4:00 PM
+0.27 (0.98%)
After-hours: Jun 18, 2024, 5:32 PM EDT

HealthStream Revenue

HealthStream had revenue of $282.88M in the twelve months ending March 31, 2024, with 4.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $72.76M with 5.53% year-over-year growth. In the year 2023, HealthStream had annual revenue of $279.06M with 4.59% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
838.98M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023279.06M12.24M4.59%
Dec 31, 2022266.83M10.11M3.94%
Dec 31, 2021256.71M11.89M4.85%
Dec 31, 2020244.83M-9.29M-3.65%
Dec 31, 2019254.11M22.50M9.71%
Dec 31, 2018231.62M16.72M7.78%
Dec 31, 2017214.90M22.78M11.85%
Dec 31, 2016192.12M-16.88M-8.08%
Dec 31, 2015209.00M38.31M22.45%
Dec 31, 2014170.69M38.42M29.04%
Dec 31, 2013132.27M28.54M27.52%
Dec 31, 2012103.73M21.67M26.40%
Dec 31, 201182.07M16.31M24.81%
Dec 31, 201065.75M8.36M14.56%
Dec 31, 200957.40M5.80M11.24%
Dec 31, 200851.60M7.65M17.41%
Dec 31, 200743.95M12.17M38.28%
Dec 31, 200631.78M4.42M16.17%
Dec 31, 200527.36M7.30M36.41%
Dec 31, 200420.06M1.86M10.23%
Dec 31, 200318.20M2.41M15.23%
Dec 31, 200215.79M2.29M16.93%
Dec 31, 200113.50M3.85M39.90%
Dec 31, 20009.65M7.08M275.87%
Dec 31, 19992.57M851.77K49.63%
Dec 31, 19981.72M447.74K35.30%
Dec 31, 19971.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Silk Road Medical 185.49M
Standard BioTools 126.76M
Arcturus Therapeutics Holdings 124.53M
Stoke Therapeutics 7.85M
Mesoblast 7.25M
Abivax 5.13M
ARS Pharmaceuticals 10.00K
Revenue Rankings